Lisata Therapeutics
As of the edition of 20 October 2026, Lisata Therapeutics runs 11 drugs.
Sources: ClinicalTrials.gov, FDA Orange Book and Purple Book, other approval registers, company records.
Family history
The records place 2 company names in this family.
- Marea Therapeutics: acquired in 2026; successor Lisata Therapeutics, Inc.
Drugs by status
| Status | Count |
|---|---|
| Active | 2 |
| Went quiet | 4 |
| Stopped | 3 |
| Status not established | 2 |
| Total | 11 |
Where its trials are
- Hormones: 5 trials led
- Nutrition and metabolism: 5 trials led
- Heart and blood vessels: 4 trials led